Holst JJ - Search Results

1

Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.

Hansen KB, Vilsbøll T, Bagger JI, Holst JJ, Knop FK. Hansen KB, et al. Among authors: holst jj. J Clin Endocrinol Metab. 2010 Jul;95(7):3309-17. doi: 10.1210/jc.2010-0119. Epub 2010 Apr 21. J Clin Endocrinol Metab. 2010. PMID: 20410219

2

Short time effects of growth hormone on glucose metabolism and insulin and glucagon secretion in normal man.

Busch-Sørensen M, Holst JJ, Lyngsøe J. Busch-Sørensen M, et al. Among authors: holst jj. J Endocrinol Invest. 1991 Jan;14(1):25-30. doi: 10.1007/BF03350253. J Endocrinol Invest. 1991. PMID: 1675225 Clinical Trial.

3

All products of proglucagon are elevated in plasma from uremic patients.

Orskov C, Andreasen J, Holst JJ. Orskov C, et al. Among authors: holst jj. J Clin Endocrinol Metab. 1992 Feb;74(2):379-84. doi: 10.1210/jcem.74.2.1730817. J Clin Endocrinol Metab. 1992. PMID: 1730817

4

Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach.

Orskov C, Holst JJ, Nielsen OV. Orskov C, et al. Among authors: holst jj. Endocrinology. 1988 Oct;123(4):2009-13. doi: 10.1210/endo-123-4-2009. Endocrinology. 1988. PMID: 2901341

5

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo.

Deacon CF, Johnsen AH, Holst JJ. Deacon CF, et al. Among authors: holst jj. J Clin Endocrinol Metab. 1995 Mar;80(3):952-7. doi: 10.1210/jcem.80.3.7883856. J Clin Endocrinol Metab. 1995. PMID: 7883856

6

Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man.

Hvidberg A, Nielsen MT, Hilsted J, Orskov C, Holst JJ. Hvidberg A, et al. Among authors: holst jj. Metabolism. 1994 Jan;43(1):104-8. doi: 10.1016/0026-0495(94)90164-3. Metabolism. 1994. PMID: 8289665

7

Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable.

Orskov C, Wettergren A, Holst JJ. Orskov C, et al. Among authors: holst jj. Diabetes. 1993 May;42(5):658-61. doi: 10.2337/diab.42.5.658. Diabetes. 1993. PMID: 8482423

8

Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique.

Hother-Nielsen O, Henriksen JE, Holst JJ, Beck-Nielsen H. Hother-Nielsen O, et al. Among authors: holst jj. Metabolism. 1996 Jan;45(1):82-91. doi: 10.1016/s0026-0495(96)90204-8. Metabolism. 1996. PMID: 8544782 Clinical Trial.

9

Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients.

Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA. Willms B, et al. Among authors: holst jj. J Clin Endocrinol Metab. 1996 Jan;81(1):327-32. doi: 10.1210/jcem.81.1.8550773. J Clin Endocrinol Metab. 1996. PMID: 8550773 Clinical Trial.

10

The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones.

Toft-Nielson M, Madsbad S, Holst JJ. Toft-Nielson M, et al. Among authors: holst jj. Diabetes. 1996 May;45(5):552-6. doi: 10.2337/diab.45.5.552. Diabetes. 1996. PMID: 8621002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,782 results

Search Page

Filters